Thyroid Cancer Trial, Recruiting (NCT06158360)

Thyroid Cancer Trial, Recruiting NCT06158360 Sponsor: Ilsan Cha hospital Condition: Thyroid Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06158360 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Thyroid Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 19 years of age or older
You have been confirmed to have a malignant (cancerous) tumor of the thyroid gland, either through a biopsy or imaging scan
You have had part or all of your thyroid gland surgically removed within the last 1 month
You are willing to receive Traditional Chinese Medicine as part of your treatment
You are able to carry out basic daily activities, or may need some help but are not completely bedridden (confirm with trial site)
You understand what the study involves and have agreed to take part

Who may not be able to join:

You have another serious condition besides cancer (such as dementia, a stroke-related illness, or severe organ failure) that may significantly affect your physical ability
Your doctors estimate that you may have less than 3 months to live, making it difficult to complete the required follow-up visits
You need urgent or major surgery that would take priority over your post-operative cancer treatment
You are currently pregnant or breastfeeding
You are considered unsuitable for the study for other reasons, as judged by the research team (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jee Youg Lee, Ilsan Cha hospital

Phone: 082-31-782-3113

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06158360

Sponsor: Ilsan Cha hospital

Phase: Not Applicable

Status: Recruiting

Condition: Thyroid Cancer

Trial contact: 082-31-782-3113

More information: https://clinicaltrials.gov/study/NCT06158360

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 19 years of age or older
You have been confirmed to have a malignant (cancerous) tumor of the thyroid gland, either through a biopsy or imaging scan
You have had part or all of your thyroid gland surgically removed within the last 1 month
You are willing to receive Traditional Chinese Medicine as part of your treatment
You are able to carry out basic daily activities, or may need some help but are not completely bedridden (confirm with trial site)
You understand what the study involves and have agreed to take part

Who may not be able to join:

You have another serious condition besides cancer (such as dementia, a stroke-related illness, or severe organ failure) that may significantly affect your physical ability
Your doctors estimate that you may have less than 3 months to live, making it difficult to complete the required follow-up visits
You need urgent or major surgery that would take priority over your post-operative cancer treatment
You are currently pregnant or breastfeeding
You are considered unsuitable for the study for other reasons, as judged by the research team (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Ilsan Cha hospital

Registry

ClinicalTrials.gov

Start date

1 December 2023

Est. completion

31 December 2029

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

THYCA-QoL score at the time of discharge (1w) of hospitalization performed for postoperative management purposes

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov